Kairos Pharma (KAPA) vs XORTX Therapeutics (XRTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
XORTX Therapeutics is the larger company by market cap ($3.4 million vs $3.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | KAPA | XRTX |
|---|---|---|
| Share price | $0.9595 | $1.85 |
| Market cap | $3.25M | $3.36M |
| 1-day change | +10.29% | +6.02% |
| Forward P/E | — | 2.31 |
| EPS (TTM) | $-1.96 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.59 | $7.05 |
| 52-week low | $0.848 | $1.59 |
| Distance from 52-week high | -89.99% | -73.76% |
| Average volume | 512.51K | 225.78K |
| Shares outstanding | 3.39M | 1.82M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
KAPA vs XRTX FAQ
Which is bigger, Kairos Pharma or XORTX Therapeutics?
XORTX Therapeutics (XRTX) is larger, with a market capitalization of $3.36M compared with $3.25M for Kairos Pharma (KAPA).
Are Kairos Pharma and XORTX Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.